Predictors of health-related quality of life in Parkinson's disease GD Kuhlman, JL Flanigan, SA Sperling, MJ Barrett Parkinsonism & related disorders 65, 86-90, 2019 | 120 | 2019 |
Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease MJ Barrett, SA Sperling, JC Blair, CS Freeman, JL Flanigan, ME Smolkin, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (11), 1251-1256, 2019 | 55 | 2019 |
Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia MJ Barrett, ME Smolkin, JL Flanigan, BB Shah, MB Harrison, SA Sperling Parkinsonism & Related Disorders 43, 56-60, 2017 | 45 | 2017 |
Brain MRI reveals ascending atrophy in Parkinson's disease across severity JC Blair, MJ Barrett, J Patrie, JL Flanigan, SA Sperling, WJ Elias, ... Frontiers in neurology 10, 1329, 2019 | 25 | 2019 |
Clinical and demographic correlates of apathy in Parkinson’s disease DS Brown, MJ Barrett, JL Flanigan, SA Sperling Journal of neurology 266, 507-514, 2019 | 20 | 2019 |
Cholinergic nucleus 4 atrophy and gait impairment in Parkinson’s disease WA Dalrymple, DS Huss, J Blair, JL Flanigan, J Patrie, SA Sperling, ... Journal of Neurology 268, 95-101, 2021 | 17 | 2021 |
Investigation of genetic variants associated with Alzheimer disease in Parkinson disease cognition MJ Barrett, AF Koeppel, JL Flanigan, SD Turner, BB Worrall Journal of Parkinson's Disease 6 (1), 119-124, 2016 | 13 | 2016 |
Comparison of Parkinson’s disease patients’ characteristics by indication for deep brain stimulation: men are more likely to have DBS for tremor WA Dalrymple, A Pusso, SA Sperling, JL Flanigan, DS Huss, MB Harrison, ... Tremor and Other Hyperkinetic Movements 9, 2019 | 12 | 2019 |
Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease MJ Barrett, JM Murphy, J Zhang, JC Blair, JL Flanigan, H Nawaz, ... Parkinsonism & Related Disorders 90, 27-32, 2021 | 11 | 2021 |
The effect of education on symptom onset and severity of Huntington's disease KK Cain, JL Flanigan, WA Dalrymple, J Patrie, MB Harrison, MJ Barrett Movement Disorders Clinical Practice 8 (4), 555-562, 2021 | 7 | 2021 |
Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson’s disease SA Sperling, J Druzgal, JC Blair, JL Flanigan, SL Stohlman, MJ Barrett The Clinical Neuropsychologist 37 (3), 676-694, 2023 | 5 | 2023 |
Predictors of anxiety in Parkinson’s disease: results from a 3-year longitudinal cohort study JS Gibson, JL Flanigan, JT Patrie, WA Dalrymple, MB Harrison Neurological Sciences 44 (2), 547-556, 2023 | 5 | 2023 |
Cognitive Predictors of Quality of Life in Parkinson’s Disease: A Three-year Longitudinal Study (P4-3.018) K Henry, S Trach, J Flanigan, J Patrie, M Harrison, M Barrett, B Shah, ... Neurology 102 (17_supplement_1), 2615, 2024 | | 2024 |
Longitudinal study of clinical symptoms associated with psychosis in Parkinson's disease without dementia J Flanigan, M Harrison, B Shah, J Patrie, K Wyman-Chick, W Dalrymple, ... MOVEMENT DISORDERS 37, S368-S368, 2022 | | 2022 |
Cholinergic Degeneration is Associated with Slower Gait in Parkinson’s Disease (5023) W Dalrymple, D Huss, J Blair, J Flanigan, S Sperling, B Shah, M Harrison, ... Neurology 94 (15_supplement), 5023, 2020 | | 2020 |
Predictors of change in cholinergic basal forebrain volume in early Parkinson disease (S41. 002) M Barrett, J Zhang, J Murphy, J Flanigan, J Blair, J Druzgal Neurology 92 (15_supplement), S41. 002, 2019 | | 2019 |
Men Are More Likely to Have DBS for Tremor in Parkinson’s Disease (P1. 8-035) W Dalrymple, S Sperling, J Flanigan, M Harrison, B Shah, M Barrett Neurology 92 (15_supplement), P1. 8-035, 2019 | | 2019 |
Cholinergic Nucleus 4 Density and Cognition in Parkinson Disease MJ Barrett, SA Sperling, JL Flanigan, ME Smolkin, JC Blair, TJ Druzgal ANNALS OF NEUROLOGY 84, S89-S89, 2018 | | 2018 |
Predictors of health-related quality of life in Parkinson's disease G Kuhlman, M Barrett, J Flanigan NEUROLOGY 90, 2018 | | 2018 |
Predictors of health-related quality of life in Parkinson’s disease (P2. 069) G Kuhlman, M Barrett, J Flanigan Neurology 90 (15_supplement), P2. 069, 2018 | | 2018 |